EBR Systems announced that it received commitments for a fully underwritten institutional placement to raise $36.1 million ...

According to the study’s abstract in The Lancet, TAVR with Acurate neo2 failed to meet non-inferiority. It also resulted in ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Cardiawave shared positive 12-month results from a study evaluating its Valvosoft non-invasive ultrasound therapy (NIUT) ...

Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

TriCares today shared results from a first-in-human trial supporting its Topaz transcatheter tricuspid valve replacement ...

Endiatx co-founder and former CEO Torrey Smith tells MassDevice he's "doing advanced PillBot R&D" and called his replacement "awesome." ...

Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

Auxilium Biotechnologies has enrolled the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).